Together, these findings suggest that enhancing insulin signaling directly in the central nervous system, rather than depending on systemic glucose-driven insulin, provides a safer and more targeted approach for maintaining mitochondrial integrity and supporting neurogenesis in AD. Here, INS is linked to Alzheimer disease.